Stock Analysts’ updated eps estimates for Wednesday, August 30th:

Bertrandt AG (ETR:BDT) had its neutral rating reiterated by analysts at DZ Bank AG.

Companhia Brasileira de Distribuicao (NYSE:CBD) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $26.00 price target on the stock. According to Zacks, “Estimates have been rising since CBD reported improved second quarter 2017 sales, driven by strong improvement in Extra Hiper markets and consistent growth at Assai. However, the reported quarter’s growth was lower than the preceding quarter’s growth. Nevertheless, shares of the company have outperformed the industry over the last six months. Strong customer traffic expansion and increase in sales volume, offsetting the effect of the slowdown in food inflation. Further, higher gross margins and a decline in selling, general and administrative expenses at Multivarejo boosted EBITDA margin. We are encouraged by company’s operating efficiency and productivity projects. Store openings and conversion of Extra Hiper stores to Assai is also boosting sales and will help accelerate the expansion of GPA’s cash-and-carry banner into new cities across Brazil. However, challenging economic scenario in Brazil remains a concern.”

ENI S.p.A. (NYSE:E) had its buy rating reissued by analysts at Citigroup Inc..

ImmunoGen (NASDAQ:IMGN) had its buy rating reissued by analysts at Canaccord Genuity. They currently have a $10.00 price target on the stock, up from their previous price target of $8.00.

Imperial Brands PLC (LON:IMT) was given a GBX 4,100 ($53.03) price target by analysts at Deutsche Bank AG. The firm currently has a buy rating on the stock.

Citigroup Inc. started coverage on shares of Ocado Group PLC (LON:OCDO). Citigroup Inc. issued a buy rating and a GBX 400 ($5.17) price target on the stock.

Ollie’s Bargain Outlet Holdings (NASDAQ:OLLI) was given a $41.00 target price by analysts at Buckingham Research. The firm currently has a hold rating on the stock.

Prosiebensat 1 Media SE (ETR:PSM) had its neutral rating reaffirmed by analysts at J P Morgan Chase & Co.

Prosiebensat 1 Media SE (ETR:PSM) was given a €24.00 ($28.57) target price by analysts at Oddo Bhf. The firm currently has a sell rating on the stock.

Prosiebensat 1 Media SE (ETR:PSM) was given a €32.00 ($38.10) price target by analysts at UBS AG. The firm currently has a neutral rating on the stock.

Silicon Motion Technology Corporation (NASDAQ:SIMO) was upgraded by analysts at Standpoint Research from a reduce rating to a buy rating.

Tabula Rasa Healthcare (NASDAQ:TRHC) had its price target increased by UBS AG from $18.00 to $25.00. They currently have a buy rating on the stock.

vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $5.50 target price on the stock. According to Zacks, “vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical trials; type II diabetes drug candidates include Glucokinase Activator TTP399 and GLP-1r Agonist TTP273 which completed Phase I clinical trials; products for the prevention of muscle weakness and treatment of inflammatory disorders include HPP593, HPP737 and HPP971 which is in Phase1 clinical trials. The Company’s drug discovery platform consists of TTP Translational Technology. vTv Therapeutics Inc. is headquartered in High Point, North Carolina. “

VWR Corporation (NASDAQ:VWR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $37.00 price target on the stock. According to Zacks, “VWR’s second-quarter earnings report was quite impressive, with both the top and the bottom line beating the Zacks Consensus Estimate. Geographically, the company recorded growth in Americas during the reported quarter driven by strong sales of equipment and instrumentation. Management is also looking forward to the long-term synergy benefits from the proposed merger with Avantor. The merger is expected to strengthen VWR’s business across the Americas and Europe. While we await the merger to close in the fourth quarter of 2017 we note that the stock price has already reached close to Avantor’s offer price and hence the short-term upside potential of VWR is limited now. On the flip side, a drop in EMEA-APAC sales was disappointing. Moreover, foreign currency was a major dampener. VWR’s poor margin scenario also raises concern.”

Wabco Holdings (NYSE:WBC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $156.00 target price on the stock. According to Zacks, “WABCO is one of the world’s leading providers of electronic braking, stability, suspension and transmission control systems for heavy duty commercial vehicles. WABCO products are also increasingly used in luxury cars and sport utility vehicles. “

Wentworth Resource Ord (NASDAQ:WENTF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Wentworth Resources Ltd. is an oil & gas company with: natural gas production; exploration and appraisal opportunities; large-scale gas monetisation initiatives primarily in the Rovuma Delta Basin of coastal southern Tanzania and northern Mozambique. Wentworth Resources Ltd. is headquartered in Calgary, Canada. “

William Hil Adr (OTCMKTS:WIMHY) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $15.00 price target on the stock. According to Zacks, “William Hill PLC provides sports betting and gaming services. It offers licensed betting offices, telephone based-betting operations and online betting, offers odds and takes bets on an assortment of sporting and other events. The company operates primarily in the United Kingdom, Australia, the United States, Italy and Spain. William Hill PLC is headquartered in London, the United Kingdom. “

Windtree Therapeutics (NASDAQ:WINT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $0.25 price target on the stock. According to Zacks, “Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. The company’s proprietary technology platform includes a synthetic, peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree Therapeutics, Inc., formerly known as Discovery Laboratories Inc., is based in Warrington, Pennsylvania. “

Westar Energy (NYSE:WR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Westar Energy, Inc. is Kansas’ largest electric utility. Westar has 7,200 MW of electric generation capacity fueled by coal, uranium, natural gas, wind and landfill gas. They are a leader in electric transmission in Kansas. Their innovative customer service programs include mobile-enabled customer care, digital meters and paving the way for electric vehicle adoption. “

Zurich Insurance Group AG (VTX:ZURN) was given a CHF 304 target price by analysts at J P Morgan Chase & Co. The firm currently has a neutral rating on the stock.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.